OpenBilldrug price receipt

NADAC week of 2026-10-14

LITHIUM CARBONATE 150 MG CAP

For 30 capsules

Pharmacies pay

$2.89 filed

30 × $0.09634 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.11 filed

30 × $0.13711 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.4× estimated

Medicare paid 1.4× what pharmacies pay.

Part D averages every strength and form sold under “Lithium Carbonate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$8.32 estimated

$2.89 + $0.43 (15%) + $5.00 fee per fill = $8.32

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LITHIUM CARBONATE 150 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lithium carbonate, under the trade name “LITHIUM CARBONATE LITHIUM CARBONATE”.

FDA gives its dosage form as “capsule, gelatin coated” and “capsule” and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Camber Pharmaceuticals, Inc. and Alembic Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Mood Stabilizer.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.89 for 30 capsules (30 × $0.09634 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 5 NDCs

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name lithium carbonate with LITHIUM CARBONATE 150 MG CAP.

ProductPharmacies pay per unitMedicare per unit
LITHIUM CARBONATE 150 MG CAP this page
generic · capsule, gelatin coated / capsule
$0.09634 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 300 MG CAP
generic · capsule, gelatin coated / capsule
$0.10387 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 300 MG TAB
generic · tablet
$0.19092 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE 600 MG CAP
generic · capsule, gelatin coated / capsule
$0.24258 per EA filed
eff. 2026-09-23
$0.13711 per EA filed
Part D 2024 average
LITHIUM CARBONATE ER 300 MG TB
generic · tablet, extended release / tablet, film coated, extended release
$0.1963 per EA filed
eff. 2026-09-23
$0.2185 per EA filed
Part D 2024 average
LITHIUM CARBONATE ER 450 MG TB
generic · tablet, extended release / tablet
$0.25902 per EA filed
eff. 2026-09-23
$0.2185 per EA filed
Part D 2024 average
LITHOBID ER 300 MG TABLET
brand · tablet, film coated, extended release
$12.01942 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $0.09634 per EA filed.

Of the 72 other products in FDA’s Mood Stabilizer class priced per EA, 62 have a higher middle NADAC price and 10 a lower one. The one in the middle is LAMOTRIGINE ODT 50 MG TABLET, at $1.27096 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.11 for 30 capsules, at an average of $0.13711 per EA in 2024 (2024-01-01 to 2024-12-31) for “Lithium Carbonate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 724,316 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for LITHIUM CARBONATE 150 MG CAP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Lithium Carbonate / Lithium Carbonate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.